
|Articles|October 1, 2001
Verteporfin for injection
The FDA has approved Visudyne (verteporfinfor injection) therapy for the treatment of predominantly classic subfovealchoroidal neovascularization (CNV) caused by pathologic myopia and presumedocular histoplasmosis.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Eyes on May 2026: A month of durable therapies, a regulatory reversal, and rethought echanisms
2
Midyear cataract check-in: What 2026 has brought to the OR and beyond
3
Beyond the Walls: Leading with love, loyalty, and a team first philosophy with Vance Thompson, MD
4
Durability With Aflibercept 8 mg in Retinal Vascular Diseases
5





















